Ding, Y. and Liu, W. (2026) “Efficacy and Safety of Xeligekimab Compared to Other IL-17A Inhibitors for Chinese Patients with Moderate-to-severe Plaque Psoriasis: A Matching-adjusted Indirect Comparisons”, Acta Dermato-Venereologica, 106, pp. adv–2025. doi: 10.2340/actadv.v106.adv-2025-0183.